Table 1.
Anti-Cancer Drug | Cancer Type | Drug Loading Method | HNTs Modification | Therapeutic Effect | References |
---|---|---|---|---|---|
Doxorubicin | Breast cancer | Immersion method | HNTs surface-modified with folic acid (FA) through PEG linker | Inhibited proliferation and induced death of MFC-7 cells | [33] |
Doxorubicin | Tumors with overexpression of FA receptor | Immersion method | HNTs conjugated with magnetic particles (Fe3O4) and FA | Enhanced toxicity to HeLa cells | [42] |
Doxorubicin | Breast cancer | Immersion method | HNTs grafted with chitosan oligosaccharide (COS) | Inhibited proliferation and induced death of MFC-7 cells | [44] |
Doxorubicin | Acute myeloid leukemia | Immersion method | Loading HNTs with gold nanorods (GNRs) and conjugating them with FA via reaction. with bovine serum albumin (BSA). | Inhibited proliferation and induced death of MFC-7 cells, decreased drug toxicity | [45] |
Cervical cancer Colon cancer Hepatocellular carcinoma |
Immersion method | HNTs immobilized with drug-loaded liposomes surface-modified with E-selectin | Increased number of MCF7 and COLO 205 cells captured | [46] | |
Lung cancer Prostate cancer Melanoma |
Immersion method | HNTs coated by thermal spraying of DOX loaded HNTs ethanol dispersion and conjugated with anti-EpCAM antibody | Enhanced toxicity to HeLa cells | [47] | |
Curcumin | Breast cancer Acute myeloid leukemia |
Drug covalently attached to the HNTs surface | Microwave-assisted synthesis of HNTs conjugated with curcumin- HNTs modified with 3-Aminopropyltriethoxysilane (APTES) or 3-Glycidoxypropyltrimethoxysilane (GPTMS) by electrospinning | Enhanced toxicity to SUM 149, MCF-7, and MDA-MB-231 breast cancer cell lines also to HL60 and HL60R myeloid leukemia cell lines | [48,49] |
Resveratrol | Breast cancer | Vaccume pump method | HNTs were coated with polyelectrolytes (PAH or PRM and PSS or DXS) using LbL method | Restrained proliferation and induced death of MFC-7 cells | [43] |
Celecoxib | Colon cancer | Immersion method | HNTs modified with pH-responsive microspheres | Inhibited proliferation of colon cancer cells | [50] |
Atorvastatin | Colon cancer | Immersion method | HNTs modified with pH-responsive microspheres | Inhibited proliferation of colon cancer cells | [50] |
Methotrexate | Osteosarcoma | Immersion method | no further modifications | Induced apoptosis and significantly inhibited proliferation of cancer cells | [51,52] |
Artemisinin | Osteosarcoma | Immersion method | no further modifications | Induced apoptosis and significantly inhibited proliferation of cancer cells | [51] |
Quercetin | Osteosarcoma | Immersion method | no further modifications | Induced apoptosis and significantly inhibited proliferation of cancer cells | [51] |
Taurolidine | Osteosarcoma | Immersion method | no further modifications | Induced apoptosis and significantly inhibited proliferation of cancer cells | [51] |
Camptothecin | Colon cancer | Surface attachment of the drug | HNTs modified with magnetic particles (FeCl3∙6H2O and FeSO4∙7H2O) then conjugated with COS, Camptothecin (CPT), and FA | Induced apoptosis of Caco-2 cancer cells | [28] |